Items where authors include "Desai, M."

Article

Abac, A.G., Abouelfettouh, I., Acernese, F. et al. (1778 more authors) (2025) GW250114: Testing Hawking’s area law and the Kerr nature of black holes. Physical Review Letters, 135 (11). 111403. ISSN 0031-9007

Keating, C., Yonker, L.M., Vermeulen, F. et al. (320 more authors) (2025) Vanzacaftor–tezacaftor–deutivacaftor versus elexacaftor–tezacaftor–ivacaftor in individuals with cystic fibrosis aged 12 years and older (SKYLINE Trials VX20-121-102 and VX20-121-103): results from two randomised, active-controlled, phase 3 trials. The Lancet Respiratory Medicine, 13 (3). pp. 256-271. ISSN 2213-2600

Zhong, J. orcid.org/0000-0001-5325-3739, Singh, A.A. orcid.org/0000-0002-9099-4162, Safdar, N.Z. et al. (106 more authors) (2024) Evaluating current acute aortic syndrome pathways: Collaborative Acute Aortic Syndrome Project (CAASP). BJS Open, 8 (5). zrae096. ISSN 2474-9842

Hayes, R., Nutland, W., Rayment, M. et al. (11 more authors) (2023) “Sex without fear”: exploring the psychosocial impact of oral HIV pre-exposure prophylaxis on gay men in England. AIDS Research and Therapy, 20. 81. ISSN 1742-6405

Orchard, K., Dignan, F.L., Lee, J. et al. (6 more authors) (2021) The NICE COVID‐19 rapid guideline on haematopoietic stem cell transplantation: development, implementation and impact. British Journal of Haematology, 192 (3). pp. 467-473. ISSN 0007-1048

Gafos, M., Brodnicki, E., Desai, M. et al. (27 more authors) (2017) Acceptability of an open-label wait-listed trial design: Experiences from the PROUD PrEP study. PLOS ONE, 12 (4). e0175596.

Dolling, D.I., Desai, M., McOwan, A. et al. (22 more authors) (2016) An analysis of baseline data from the PROUD study: an open-label randomised trial of pre-exposure prophylaxis. Trials, 17 (1). ISSN 1745-6215

McCormack, S., Dunn, D.T., Desai, M. et al. (24 more authors) (2016) Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial. The Lancet, 387 (10013). pp. 53-60. ISSN 0140-6736